Acute pyelonephritis in children: antibiotic therapy depending on the clinical context

Area of Science:

• Pediatric Infectious Diseases
• Antimicrobial Stewardship

Background:

• Acute pyelonephritis is a serious kidney infection in children.
• Complicated cases or those at risk require specific treatment strategies.
• Antimicrobial susceptibility testing is crucial for effective treatment.

Purpose of the Study:

• To outline recommended antibiotic treatment guidelines for pediatric acute pyelonephritis.
• To differentiate treatment approaches for complicated versus uncomplicated cases.
• To emphasize the importance of tailoring therapy based on bacterial resistance patterns.

Main Methods:

• Review of current clinical guidelines and evidence for pediatric pyelonephritis management.
• Analysis of recommended parenteral and oral antibiotic regimens.
• Consideration of treatment duration and alternative therapies.

Main Results:

• Complicated cases: initial parenteral antibiotics (e.g., ceftriaxone) for 2-4 days, followed by oral therapy for 10-14 days total.
• Uncomplicated cases: first-line oral cefixime for 7-10 days.
• Second-line oral options include amoxicillin/clavulanic acid or co-trimoxazole, guided by susceptibility results.

Conclusions:

• A stepwise approach combining parenteral and oral antibiotics is effective for complicated pediatric pyelonephritis.
• Oral cefixime is a primary choice for uncomplicated infections.
• Treatment decisions must incorporate antimicrobial susceptibility data for optimal outcomes.